Two Sigma Advisers
VXRT

Two Sigma Advisers’s Vaxart VXRT Stock Holding History

Two Sigma Advisers’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-24,700
Closed -$16.4K – 2598
2024
Q4 		$16.4K Buy
+24,700
New +$17.2K ﹤0.01% 2325
2023
Q3 		– Sell
-179,900
Closed -$131K – 2592
2023
Q2 		$131K Sell
179,900
-919,600
-84% -$855K ﹤0.01% 2177
2023
Q1 		$832K Sell
1,099,500
-957,500
-47% -$889K ﹤0.01% 1724
2022
Q4 		$1.98M Buy
2,057,000
+2,041,500
+13,171% +$2.89M 0.01% 1257
2022
Q3 		$34K Buy
+15,500
New +$53.5K ﹤0.01% 2405
2022
Q2 		– Sell
-37,700
Closed -$190K – 2888
2022
Q1 		$190K Sell
37,700
-5,500
-13% -$27.9K ﹤0.01% 2393
2021
Q4 		$271K Buy
+43,200
New +$295K ﹤0.01% 2172

Other funds holding VXRT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Two Sigma Advisers's VXRT Position: Q1 2025 in Review

Two Sigma Advisers sold out of Vaxart (VXRT) in Q1 2025, closing a stake of 24,700 shares — an estimated $16.4K sold.

Two Sigma Advisers first reported a position in VXRT in Q4 2021 and held it in 7 quarters. The position peaked at $1.98M in Q4 2022. 92 funds tracked by Wall St. Rank hold VXRT as of Q1 2025.

  • Two Sigma Advisers reported no remaining Vaxart position as of Q1 2025 after selling out during the quarter.
  • Two Sigma Advisers sold 24,700 Vaxart shares in Q1 2025, an estimated $16.4K.
  • Two Sigma Advisers first reported a position in Vaxart in Q4 2021 and held it in 7 quarters.
  • Two Sigma Advisers's Vaxart position peaked at $1.98M in Q4 2022.
  • 92 funds tracked by Wall St. Rank held Vaxart as of Q1 2025.

Based on Two Sigma Advisers's 13F filing for Q1 2025, filed 15 May 2025.